Technology · 6 views
Araceli raises $4.5M for drug discovery tools aimed at reducing animal testing
Oregon-based Araceli Biosciences raised $4.5 million to commercialize cell-imaging tools that help researchers test potential drugs using human cells, with the aim of reducing reliance on animal studies while producing more relevant…
Summary
Oregon-based Araceli Biosciences raised $4.5 million to commercialize cell-imaging tools that help researchers test potential drugs using human cells, with the aim of reducing reliance on animal studies while producing more relevant results.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Technology
Continue reading recent Technology coverage
- Jensen Huang’s departure blasts big hole in AI startup funding, VCs and founders sayContinue reading
- US government grounds all flights across the United States ‘due to extraordinary circumstances’Continue reading
- Chinese AI labs are training models on Nvidia's Blackwell despite export controls, says ex-OpenAI engineerContinue reading
- Microsoft doesn’t ‘have an ETA for full recovery’ on outage yetContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow